Spontaneous bacterial peritonitis
Spontaneous bacterial peritonitis is a monomicrobial infection of cirrhotic ascitic fluid without a surgical source, diagnosed by an ascitic fluid neutrophil count of 250 cells/microL or higher on paracentesis. Treatment is prompt IV third-generation cephalosporin plus IV albumin in patients with renal or hepatic dysfunction, followed by indefinite secondary antibiotic prophylaxis because recurrence is common.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Definition: spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid in a patient with portal hypertension, occurring without perforation, abscess, or another surgically treatable source.
- Epidemiology
Prevalence: SBP develops in 10% to 20% of patients with cirrhosis and ascites, making diagnostic paracentesis routine whenever ascitic fluid is first encountered or a cirrhotic patient decompensates.
- Risk factors
Cirrhotic ascites with low ascitic protein: protein less than 1.0 to 1.5 g/dL is the strongest single predictor, reflecting reduced opsonic capacity.
- Pathophysiology
Portal hypertension is the prerequisite: cirrhosis with portal hypertension produces splanchnic vasodilation, gut wall edema, and slowed intestinal transit that favor bacterial overgrowth.
- Clinical features
Fever, diffuse abdominal pain, and abdominal tenderness: the classic triad, though a fluid wave with a tense, protuberant abdomen and no rebound tenderness is common and can mask a surgical abdomen.
- Differential diagnosis
Secondary bacterial peritonitis: infection from another intra-abdominal source such as a perforation, appendicitis, diverticulitis, cholecystitis, or infected peritoneal dialysis catheter; suspect it…
- Diagnosis
Diagnostic criterion: an ascitic fluid absolute PMN (neutrophil) count of 250 cells/microL (0.25 x 10^9/L) or higher on paracentesis establishes SBP regardless of culture; a positive culture supports…
- Management
Start empiric IV antibiotics immediately once the ascitic fluid PMN count is 250 cells/microL or higher, without waiting for culture results: obtain blood and ascitic fluid cultures first if this does not delay treatment.
- Complications
Hepatorenal syndrome: the most feared complication, driven by effective intravascular volume depletion from splanchnic vasodilation during infection; albumin is given specifically to reduce this risk (hepatorenal syndrome).
- Prognosis
High short-term mortality: SBP carries a high in-hospital mortality rate, driven mainly by progression to hepatorenal syndrome and septic shock when treatment is delayed.
- Prevention
Secondary prophylaxis, indefinite, after any episode of SBP: ciprofloxacin 500 mg PO once daily, continued until liver transplantation, death, or durable resolution of ascites…
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Cirrhotic ascites
Cirrhotic ascites is fluid accumulation in the peritoneal cavity driven by portal hypertension and splanchnic vasodilation, confirmed by a serum-ascites albumin gradient of 1.1 g/dL or more on diagnostic paracentesis. Management proceeds from sodium restriction and combination diuretics to large-volume paracentesis with albumin and TIPS for refractory disease, with every new or worsening episode screened for spontaneous bacterial peritonitis.
- Cirrhosis
Cirrhosis is end-stage hepatic fibrosis with regenerative nodules, staged as compensated or decompensated by the onset of ascites, variceal hemorrhage, encephalopathy, or jaundice. Severity is graded by Child-Pugh class and MELD, and management centers on treating the underlying cause, surveillance for varices and hepatocellular carcinoma, and timely transplant referral once decompensation appears.
- Hepatorenal syndrome
Hepatorenal syndrome is functional renal failure in a patient with cirrhosis and ascites, driven by splanchnic vasodilation and compensatory renal vasoconstriction, and it is diagnosed only after excluding shock, nephrotoxins, and structural kidney disease and after creatinine fails to improve with diuretic withdrawal and an albumin challenge. Treatment is a splanchnic vasoconstrictor (terlipressin first-line) with intravenous albumin as a bridge to liver transplantation, the only curative therapy.
- Hepatic encephalopathy
Hepatic encephalopathy is a reversible spectrum of brain dysfunction from insufficient hepatic clearance and portosystemic shunting of gut-derived toxins, graded by the West Haven criteria and almost always triggered by an identifiable precipitant such as infection, gastrointestinal bleeding, constipation, or an electrolyte disturbance. Diagnosis is clinical, and management proceeds by treating the precipitant first, then titrating lactulose and adding rifaximin for recurrence prevention.
- Acute upper gastrointestinal bleeding
Acute upper gastrointestinal bleeding arises proximal to the ligament of Treitz and presents with hematemesis or melena, most often from peptic ulcer disease or bleeding gastroesophageal varices. Management sequences resuscitation, restrictive transfusion, IV proton pump inhibitor therapy, and, when varices are suspected, octreotide plus antibiotic prophylaxis, all before upper endoscopy within 24 hours, which is both diagnostic and therapeutic.
- Acute appendicitis
Acute appendicitis is luminal obstruction and infection of the vermiform appendix presenting as migratory periumbilical-to-right-lower-quadrant pain, diagnosed by the classic history and exam plus confirmatory imaging (CT in adults, ultrasound or MRI in children and pregnancy), and treated with prompt appendectomy or, in selected uncomplicated cases, antibiotics alone.
- Hepatocellular carcinoma
Hepatocellular carcinoma is a primary liver cancer that arises almost exclusively in cirrhosis and can be diagnosed non-invasively when multiphase CT or MRI shows arterial-phase hyperenhancement with portal-venous washout in a lesion at least 1 cm. Treatment is stratified by tumor burden, liver function, and vascular or extrahepatic spread, ranging from resection or ablation through transplantation and transarterial chemoembolization to systemic atezolizumab-bevacizumab for advanced disease.
- Acute pancreatitis
Acute pancreatitis is acinar-cell autodigestion and inflammation of the pancreas, most often from gallstones or alcohol, diagnosed by the revised Atlanta criteria and graded mild, moderately severe, or severe by organ failure. Management centers on early goal-directed lactated Ringer's resuscitation, analgesia, early enteral feeding, and timed ERCP for gallstone pancreatitis with cholangitis, reserving antibiotics for confirmed infected necrosis.